Trial Profile
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2020
Price :
$35
*
At a glance
- Drugs Terconazole (Primary)
- Indications Infections; Vaginal diseases
- Focus Registrational; Therapeutic Use
- Acronyms SMART GIVES
- Sponsors Curatek Pharmaceuticals
- 18 Jul 2017 Status changed from active, no longer recruiting to completed.
- 24 May 2017 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.
- 24 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Jun 2017.